Yong‐Chul Kim

6.1k total citations
179 papers, 5.0k citations indexed

About

Yong‐Chul Kim is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Yong‐Chul Kim has authored 179 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Molecular Biology, 48 papers in Organic Chemistry and 47 papers in Physiology. Recurrent topics in Yong‐Chul Kim's work include Adenosine and Purinergic Signaling (46 papers), Synthesis and Biological Evaluation (26 papers) and Quinazolinone synthesis and applications (22 papers). Yong‐Chul Kim is often cited by papers focused on Adenosine and Purinergic Signaling (46 papers), Synthesis and Biological Evaluation (26 papers) and Quinazolinone synthesis and applications (22 papers). Yong‐Chul Kim collaborates with scholars based in South Korea, United States and United Kingdom. Yong‐Chul Kim's co-authors include Kenneth A. Jacobson, Xiao‐duo Ji, Junji Yodoi, Hiroshi Masutani, Neli Melman, Joel Linden, Jin-Hee Park, Jae Il Kim, Isak Im and Hyojin Ko and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Clinical Investigation.

In The Last Decade

Yong‐Chul Kim

175 papers receiving 4.9k citations

Peers

Countries citing papers authored by Yong‐Chul Kim

Since Specialization

Citations

This map shows the geographic impact of Yong‐Chul Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong‐Chul Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong‐Chul Kim more than expected).

Fields of papers citing papers by Yong‐Chul Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong‐Chul Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong‐Chul Kim. The network helps show where Yong‐Chul Kim may publish in the future.

Co-authorship network of co-authors of Yong‐Chul Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Yong‐Chul Kim. A scholar is included among the top collaborators of Yong‐Chul Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong‐Chul Kim. Yong‐Chul Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A polycyclic scaffold identified by structure-based drug design effectively inhibits the human P2X7 receptor 2025 ·Nature Communications ·(unknown), Andreea L. Turcu, (unknown), (unknown), (unknown), (unknown), Marta Barniol‐Xicota, (unknown), (unknown), (unknown), Annette Nicke, Yong‐Chul Kim, Christa E. Müller, Antonios Kolocouris, Santiago Vázquez, Steven Mansoor	2
2	Discovery of (4-Phenyl-cyclohexyl)acetate-Derived Tyrosylprotein Sulfotransferase 2 (TPST2) Inhibitors with Potent Anti-Tumor Activity for Immuno-Oncology Applications 2025 ·Journal of Medicinal Chemistry ·(unknown), Hyun Kim, Yumi Oh, (unknown), Moongu Jeon, Yun-Jae Kim, (unknown), Jihyun Kim, (unknown), (unknown), (unknown), (unknown), (unknown), Jeongha Mok, Soo Hyun Eom, Sung‐Yup Cho, Hansoo Park, Yong‐Chul Kim	0
3	Discovery and Binding Mechanism of Pyrazoloisoquinoline-Based Novel β-Arrestin Inverse Agonists of the Kappa-Opioid Receptor 2023 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Moon Young Yang, Sunhong Kim, Soo‐Kyung Kim, William A. Goddard, Yong‐Chul Kim	1
4	Development of Dibenzothiazepine Derivatives as Multifunctional Compounds for Neuropathic Pain 2022 ·Pharmaceuticals ·Kwan‐Young Jung, Yeo Ok Kim, (unknown), Hyung Gon Lee, (unknown), (unknown), (unknown), Siwon Kim, Seon Hee Seo, Jong‐Hyun Park, Ki Duk Park, Woong Mo Kim, Myung Ha Yoon, Yong‐Chul Kim	1
5	Eltrombopag as an Allosteric Inhibitor of the METTL3-14 Complex Affecting the m6A Methylation of RNA in Acute Myeloid Leukemia Cells 2022 ·Pharmaceuticals ·(unknown), (unknown), (unknown), Mi Sun Jin, Haihong Shen, Yong‐Chul Kim	48
6	Involvement of endoplasmic reticulum stress and cell death by synthesized Pa-PDT in oral squamous cell carcinoma cells 2022 ·Journal of Dental Sciences ·Hyo‐Eun Yoon, Mee‐Young Ahn, Yong‐Chul Kim, Jung‐Hoon Yoon	7
7	Interplay among Conformation, Intramolecular Hydrogen Bonds, and Chameleonicity in the Membrane Permeability and Cyclophilin A Binding of Macrocyclic Peptide Cyclosporin O Derivatives 2021 ·Journal of Medicinal Chemistry ·(unknown), Sung‐Jin Lee, Jieun Choi, (unknown), (unknown), Min Ju Kim, Dae‐Seop Shin, Myung Ae Bae, Yong‐Chul Kim, Chin‐Ju Park, Kyeong‐Ryoon Lee, Jun‐Ho Choi, Jiwon Seo	28
8	Development of UHPLC-MS/MS Method for Indirubin-3′-Oxime Derivative as a Novel FLT3 Inhibitor and Pharmacokinetic Study in Rats 2020 ·Molecules ·(unknown), Yong‐Chul Kim, Yoon Gyoon Kim, (unknown), (unknown)	1
9	Involvement of the P2X7 receptor in the migration and metastasis of tamoxifen-resistant breast cancer: effects on small extracellular vesicles production 2019 ·Scientific Reports ·Miso Park, Ji‐Eun Kim, (unknown), (unknown), Jin‐Hee Park, Yong‐Chul Kim, (unknown), Sung‐Chul Lim, Keon Wook Kang	47
10	Discovery of Novel Biased Opioid Receptor Ligands through Structure‐Based Pharmacophore Virtual Screening and Experiment 2019 ·ChemMedChem ·(unknown), Soo‐Kyung Kim, Quanjie Li, (unknown), (unknown), Guangju Chen, Hongwei Tan, Siwon Kim, Jong‐Hyun Park, Ki Duk Park, Yeo Ok Kim, (unknown), Myung Ha Yoon, Yong‐Chul Kim, William A. Goddard	5
11	Design, synthesis and anticancer activity of fluorocyclopentenyl-purines and – pyrimidines 2018 ·European Journal of Medicinal Chemistry ·(unknown), Dnyandev B. Jarhad, Gyudong Kim, (unknown), Long Zhao, Jinha Yu, Hong‐Rae Kim, Ji Yun Lee, (unknown), Girish Chandra, Woong Sub Byun, Sang Kook Lee, Yong‐Chul Kim, Lak Shin Jeong	39
12	Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells 2018 ·European Journal of Medicinal Chemistry ·(unknown), S. H. Shin, Ji-Hyun Lee, Jin‐Kyoung Shim, Min-Jeong Kim, (unknown), Aram Lee, (unknown), Jin-Hee Park, Aliaa Abdelrahman, Christa E. Müller, Steve K. Cho, Seok‐Gu Kang, Myung Ae Bae, Jung Yoon Yang, Hyojin Ko, William A. Goddard, Yong‐Chul Kim	25
13	Characterization of the aminopyridine derivative KRC-180 as a JAK2 inhibitor 2017 ·Oncology Letters ·(unknown), Sung Yun Cho, Su An, (unknown), Hyo‐Jeong Lee, Hae-Sung Yoon, Sun‐Mi Lee, Yong‐Chul Kim, (unknown)	2
14	Myeloid-Derived Suppressor Cells Are Controlled by Regulatory T Cells via TGF-β during Murine Colitis 2016 ·Cell Reports ·Chorong Lee, (unknown), (unknown), Jung Hyun Han, Sangheon Park, (unknown), (unknown), (unknown), (unknown), Jung‐Ah Kang, Yong‐Chul Kim, Sarkis K. Mazmanian, (unknown), (unknown)	112
15	Pyrazolodiazepine derivatives with agonist activity toward Drosophila RYamide receptor 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Jung Ha Kim, (unknown), (unknown), Yong‐Chul Kim, Young‐Joon Kim, Zee‐Yong Park	2
16	A Highly Sensitive Liquid Chromatography–Electrospray Ionization–Time of Flight/Mass Spectrometric Assay for the Quantitation of 4-Beta-Hydroxycholesterol and Its Application to in vivo Cytochrome P450 3a Induction by AGM-130 2015 ·Journal of Liquid Chromatography & Related Technologies ·(unknown), Min‐Ho Park, Jin‐Ju Byeon, Yong‐Chul Kim, Young G. Shin	2
17	DEVELOPMENT OF A LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY METHOD FOR THE DETERMINATION OF INDIRUBIN-5-NITRO-3′-MONOXIME, A NOVEL CDK INHIBITOR, IN RAT PLASMA 2012 ·Journal of Liquid Chromatography & Related Technologies ·(unknown), Yong‐Chul Kim, Jae Il Kim, Yong Seok Choi, Yoon Gyoon Kim	1
18	Acute Toxicity of the BK Ca Channel Opener LDD175 2006 ·Biomolecules & Therapeutics ·Ji‐Young Choi, (unknown), (unknown), (unknown), Chul‐Seung Park, Yong‐Chul Kim, (unknown)	1
19	Electrophysiological Characterization of Benzofuroindole-Induced Potentiation of Large-Conductance Ca2+-Activated K+ Channels 2005 ·Molecular Pharmacology ·Tal Soo Ha, Hyun–Ho Lim, Ga Eun Lee, Yong‐Chul Kim, Chul‐Seung Park	19
20	Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide 2002 ·Biochemical and Biophysical Research Communications ·Sung‐Tae Yang, Song Yub Shin, Yong‐Chul Kim, Yangmee Kim, Kyung‐Soo Hahm, Jae Il Kim	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact